Characterization of spinal cord tissue-derived extracellular vesicles in neuroinflammation

Larissa Jank(Johns Hopkins University), Pavan Bhargava(Johns Hopkins University)
Journal of Neuroinflammation
June 8, 2024
10.1186/s12974-024-03147-y
Cited by 8

Related Papers

Trial of intrathecal rituximab in progressive multiple sclerosis patients with evidence of leptomeningeal contrast enhancement
|Multiple Sclerosis and Related Disorders|2019|70
A multicentre, open label, single-arm, phase 3b study (CONSONANCE) to assess the effectiveness and safety of ocrelizumab in patients with primary and secondary progressive multiple sclerosis: year-1 interim analysis (P1-1.Virtual)
|Neurology|2022|5
A multicenter, open label, single-arm, phase 3b study (CONSONANCE) to assess efficacy of ocrelizumab in patients with primary and secondary progressive multiple sclerosis: year 1 interim analysis of cognition outcomes (P1-1.Virtual)
|Neurology|2022|4